WINT - Windtree Therapeutics, Inc. Operating profit before amortization

Brandmark of windtreetx.com (WINT)

Windtree Therapeutics relies on the results of clinical trials for cardiology drugs that require external financing. Windtree Therapeutics creates unique surfactant molecules for the therapy of heart failure, maintaining a technological niche. The implementation of ESG standards and bioethics complements the development strategy. In the EBITDA_Co metric, the figure serves as a current indicator helping to assess the dynamics of operating profit and business margins.

Windtree Therapeutics - WINT Profit before payment of interest, taxes and amortization (period 07/04/2022 - 11/10/2026)

Windtree Therapeutics, Inc. (WINT) - metric breakdowns and financial figures

- share price and expert price forecast:
Share Price Windtree Therapeutics Inc.|WINT - Analyst Consensus Forecast
- market capitalization statistics:
Market Capitalization Windtree Therapeutics|WINT - Real Price to Acquire Entire Company
- balance sheet net asset value indicators:
Book Price of a Share Windtree Therapeutics|WINT - Company Book Value|Market Value to Book Value windtreetx.com|WINT - Company Total Assets
- company total debt and liquidity indicators:
Debt to Capital Windtree Therapeutics|WINT - Long-Term Debt to Capital|Current Liabilities to Capital Windtree Therapeutics Inc.|WINT - Company Total Debt|Debt to Net Assets Ratio Windtree Therapeutics|WINT - Company Long-Term Liabilities|Amount of Current Liabilities Windtree Therapeutics|Intermediate Coverage Ratio windtreetx.com
- financial results and valuation multiples details:
WINT - Net Profit|Expected Net Profit Windtree Therapeutics|WINT - Price to Earnings Ratio|Future Price to Earnings Multiple Windtree Therapeutics Inc.|WINT - PEG Multiple|EV/EBITDA Multiple Windtree Therapeutics|WINT - Profit before payment of interest, taxes and amortization|Earnings per one share for the last 12 months Windtree Therapeutics|WINT - Net earnings per share (EPS TTM)|Earnings per share growth in annualized terms for the last twelve months windtreetx.com|WINT - Net earnings per share growth this year|Earnings growth forecast for next year Windtree Therapeutics
Fundamental company valuation:Windtree Therapeutics
Manufactured product of windtreetx.com

The development of proprietary infusion products for heart failure therapy and the partnerships of Windtree Therapeutics (WINT) determine the scale of its cash flows. Monitoring EBITDA_Co reflects net operating profit before interest and taxes, stripping real sales dynamics of GAAP accounting adjustments, which allows the investor to assess the fundamental efficiency of the business regardless of debt load and paper profits.

Competitor analysis for Windtree Therapeutics

REGN: Operating profit before amortization|iRhythm Technologies - Operating profit EBITDA|LNTH (lantheus.com) - Operating profit before amortization|MLYS (Mineralys Therapeutics, Inc.) - Operating profit before deduction of amortization|HTFL: Company profit before taxes, interest and amortization|Profit before payment of interest, taxes and amortization Kestra|ESPR: Income before deduction of interest, taxes and amortization|Operating profit EBITDA AMRN|AVR - Profit before interest, taxes and amortization|Operating profit EBITDA TNYA (Tenaya Therapeutics, Inc.)|CVRx Inc. (CVRX) - Profit before interest, taxes and amortization|MIST: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization CRDL (Cardiol Therapeutics)|BEAT (HeartBeam, Inc.) - Operating profit before deduction of amortization|TENX: Company profit before taxes, interest and amortization|ADGM (Adagio Medical) - Operating profit EBITDA|BCDA: Income before deduction of interest, taxes and amortization|Operating profit EBITDA VTAK|ABIO - Profit before interest, taxes and amortization|Profit before payment of interest, taxes and amortization Acasti Pharma Inc. ACST|Income before deduction of interest, taxes and amortization AVTE|Verve - Operating profit EBITDA